First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: Clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD group study

  1. Sastre, J.
  2. Grávalos, C.
  3. Rivera, F.
  4. Massuti, B.
  5. Valladares-Ayerbes, M.
  6. Marcuello, E.
  7. Manzano, J.L.
  8. Benavides, M.
  9. Hidalgo, M.
  10. Díaz-Rubio, E.
  11. Aranda, E.
Revue:
Oncologist

ISSN: 1083-7159,  1549-490X

Année de publication: 2012

Volumen: 17

Número: 3

Pages: 339-345

Type: Article

DOI: 10.1634/THEONCOLOGIST.2011-0406 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus